|
Q2 FY2026
As of Jun 30, 2026
|
Q1 FY2026
As of Mar 31, 2026
|
Q4 FY2025
As of Dec 31, 2025
|
Q3 FY2025
As of Sep 30, 2025
|
Q2 FY2025
As of Jun 30, 2025
|
Q1 FY2025
As of Mar 31, 2025
|
Q4 FY2024
As of Dec 31, 2024
|
Q3 FY2024
As of Sep 30, 2024
|
Q2 FY2024
As of Jun 30, 2024
|
Q1 FY2024
As of Mar 31, 2024
|
Q4 FY2023
As of Dec 31, 2023
|
Q3 FY2023
As of Sep 30, 2023
|
Q2 FY2023
As of Jun 30, 2023
|
Q1 FY2023
As of Mar 31, 2023
|
Q4 FY2022
As of Dec 31, 2022
|
Q3 FY2022
As of Sep 30, 2022
|
Q2 FY2022
As of Jun 30, 2022
|
Q1 FY2022
As of Mar 31, 2022
|
Q4 FY2021
As of Dec 31, 2021
|
Q3 FY2021
As of Sep 30, 2021
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||||||||||||
| Investments: | ||||||||||||||||||||
| Fixed maturity securities available-for-sale, at estimated fair value (net of allowance for credit loss of $158 and $194, respectively); and amortized cost: $172,369 and $167,384, respectively | ||||||||||||||||||||
| Mortgage loans (net of allowance for credit loss of $822 and $701, respectively; includes $183 and $180, respectively, relating to variable interest entities) | ||||||||||||||||||||
| Policy loans | ||||||||||||||||||||
| Real estate and real estate joint ventures (includes $377 and $378, respectively, under the fair value option; $127 and $64, respectively, of real estate held-for-sale; $2,490 and $2,435, respectively, relating to variable interest entities) | ||||||||||||||||||||
| Other limited partnership interests | ||||||||||||||||||||
| Short-term investments, at estimated fair value | ||||||||||||||||||||
| Other invested assets (includes $348 and $435, respectively, of leveraged and direct financing leases; $1,806 and $866, respectively, under the fair value option, of which $800 and $0, respectively, relate to variable interest entities; $40 and $45, respectively, relating to variable interest entities not under the fair value option) | ||||||||||||||||||||
| Total investments | ||||||||||||||||||||
| Cash and cash equivalents, principally at estimated fair value (includes $83 and $0, respectively, relating to variable interest entities) | ||||||||||||||||||||
| Accrued investment income | ||||||||||||||||||||
| Premiums, reinsurance and other receivables | ||||||||||||||||||||
| Market risk benefits, at estimated fair value | ||||||||||||||||||||
| Deferred policy acquisition costs and value of business acquired | ||||||||||||||||||||
| Current income tax recoverable | ||||||||||||||||||||
| Deferred income tax asset | ||||||||||||||||||||
| Other assets | ||||||||||||||||||||
| Separate account assets | ||||||||||||||||||||
| Total assets | ||||||||||||||||||||
| Liabilities and Equity | ||||||||||||||||||||
| Liabilities | ||||||||||||||||||||
| Future policy benefits | ||||||||||||||||||||
| Policyholder account balances | ||||||||||||||||||||
| Market risk benefits, at estimated fair value | ||||||||||||||||||||
| Other policy-related balances | ||||||||||||||||||||
| Policyholder dividends payable | ||||||||||||||||||||
| Policyholder dividend obligation | ||||||||||||||||||||
| Payables for collateral under securities loaned and other transactions | ||||||||||||||||||||
| Short-term debt | ||||||||||||||||||||
| Long-term debt | ||||||||||||||||||||
| Current income tax payable | ||||||||||||||||||||
| Notes Issued by Collateralized Financing Entities | ||||||||||||||||||||
| Other liabilities (includes $45 and $0, respectively, relating to variable interest entities) | ||||||||||||||||||||
| Separate account liabilities | ||||||||||||||||||||
| Total liabilities | ||||||||||||||||||||
| Equity | ||||||||||||||||||||
| Metropolitan Life Insurance Company stockholder’s equity: | ||||||||||||||||||||
| Common stock, par value $0.01 per share; 1,000,000,000 shares authorized; 494,466,664 shares issued and outstanding | ||||||||||||||||||||
| Additional paid-in capital | ||||||||||||||||||||
| Retained earnings | ||||||||||||||||||||
| Accumulated other comprehensive income (loss) | ||||||||||||||||||||
| Total Metropolitan Life Insurance Company stockholder’s equity | ||||||||||||||||||||
| Noncontrolling interests | ||||||||||||||||||||
| Total equity | ||||||||||||||||||||
| Total liabilities and equity | ||||||||||||||||||||
Loading...
